PIPS

Swing Therapeutics Announces Positive Results from Pivotal Phase 3 Trial of Stanza, a Digital Therapy for Fibromyalgia Symptoms

Retrieved on: 
Tuesday, November 14, 2023
Biotechnology, Technology, FDA, Health, General Health, Pharmaceutical, Health Technology, Medical Devices, Apps, Applications, Software, Clinical Trials, ACT, RCT, Fatigue, Fibromyalgia, Depression, De novo, Pivotal, Randomized controlled trial, Food, Commitment, Therapy, University of Michigan, CBT, Cognitive behavioral therapy, Patient, PROMIS, American College of Rheumatology, PGIC, American College, BDI, MD, Sleep, Phase 3, University, University of Cincinnati, FIQ, Doctor of Philosophy, Guideline, ACR, Chronic pain, PIPS, Pharmaceutical industry, Medical imaging, Medical device, Stanza, Swing

Swing Therapeutics, a leading developer of digital therapies for chronic pain conditions, today announced the successful completion of and positive results from its pivotal Phase 3 PROSPER-FM trial on Stanza, a self-guided smartphone-based behavioral therapy for the treatment of fibromyalgia symptoms in adult patients.

Key Points: 
  • Swing Therapeutics, a leading developer of digital therapies for chronic pain conditions, today announced the successful completion of and positive results from its pivotal Phase 3 PROSPER-FM trial on Stanza, a self-guided smartphone-based behavioral therapy for the treatment of fibromyalgia symptoms in adult patients.
  • Results from this multi-center, randomized controlled trial (RCT) were presented at the American College of Rheumatology (ACR) 2023 annual meeting this week.
  • Swing received De Novo marketing authorization from the U.S. Food and Drug Administration (FDA) for Stanza in May 2023, making it the first prescription digital therapeutic indicated for treating fibromyalgia symptoms.
  • It delivers acceptance and commitment therapy (ACT), a type of cognitive behavioral therapy (CBT) with proven efficacy in treating fibromyalgia and other chronic pain conditions.

Scaling New Heights for a Vital Cause: Options Completes Mourne Wall Challenge to Raise £32,061 for PIPS Suicide Prevention Ireland

Retrieved on: 
Wednesday, August 30, 2023
Technology, Professional Services, Health, Philanthropy, Other Philanthropy, Mental Health, Security, Data Analytics, Artificial Intelligence, Fund Raising, Foundation, Social responsibility, Capital market, Suicide, American Lung Association, SPAR, Multimedia, Death, MAC, Option, Metropolitan, Mourne Wall, PIPS, Mourne Mountains, Mental health, Nightclub

Options Technology , the leading Capital Markets services provider, today announced it has raised £32,061 for PIPS following the completion of the Mourne Wall Challenge.

Key Points: 
  • Options Technology , the leading Capital Markets services provider, today announced it has raised £32,061 for PIPS following the completion of the Mourne Wall Challenge.
  • Today’s news marks Options’ second fundraising initiative for PIPS, building upon £25,000 previously raised through a company-wide charity auction in March 2023.
  • View the full release here: https://www.businesswire.com/news/home/20230830695981/en/
    Options today announced it has raised £32,061 for PIPS following the completion of the Mourne Wall Challenge.
  • “We are delighted to receive this generous donation from Options Technology,” said Renée Quinn , Executive Director of PIPS.

Options Partners with Queen’s University Belfast Rowing Club

Retrieved on: 
Tuesday, April 4, 2023
Technology, Finance, Consulting, Security, Professional Services, Internet, University, Data Management, Education, Social responsibility, QUB, Partnership, Travel, Capital market, Queen, American Lung Association, SME, SPAR, Multimedia, Assistant, Employment, Queen's University Belfast, Physical, British Universities and Colleges Sport, Student, MAC, BUCS, Option, Belfast, Metropolitan, Sport, PIPS, Global marketing, News, Belfast Telegraph, Management, Nursing, Philanthropy

Options Technology , the leading Capital Markets services provider, today announced it will become the new sponsor of the Queen's University Belfast Rowing Clubs.

Key Points: 
  • Options Technology , the leading Capital Markets services provider, today announced it will become the new sponsor of the Queen's University Belfast Rowing Clubs.
  • View the full release here: https://www.businesswire.com/news/home/20230404005681/en/
    Pictured left to right: Leah Murphy, Technical Support Engineer, Options Technology; James McDaid Men’s Rowing Captain; Karl Oakes, Head of Sport and Physical Wellbeing; Colleen Murray, Global Marketing, Options Technology; Helen Carrick, Assistant Director of Philanthropy; Sam McCormick, Women’s Rowing Captain; Liam Fegan, Belfast Support Team Lead, Options Technology.
  • (Photo: Business Wire)
    The partnership will see Options support Queen's Rowing, in its pursuit of success on the world stage.
  • “We are delighted to support Queen’s Rowing and to invest in the future of the club,” said Danny Moore , President and CEO of Options Technology.

Options Raises £25,000 for PIPS Suicide Prevention Ireland

Retrieved on: 
Thursday, March 16, 2023
Mental Health, Technology, Finance, Fintech, Banking, Professional Services, Software, Networks, Health, Data Management, Multimedia, PIPS, Belfast Telegraph, American Lung Association, Belfast, SME, Partnership, Mental, Capital market, Employment, Mental health, MAC, Death, Option, James Irvine Foundation, Metropolitan, SPAR, Suicide, Social responsibility, News, Nightclub, Renewable energy

Options Technology , the leading Capital Markets services provider, today announced it has raised £25,000 for PIPS Suicide Prevention Ireland, a Northern Ireland based charity that provides counselling and support to individuals and organisations that have been affected by suicide.

Key Points: 
  • Options Technology , the leading Capital Markets services provider, today announced it has raised £25,000 for PIPS Suicide Prevention Ireland, a Northern Ireland based charity that provides counselling and support to individuals and organisations that have been affected by suicide.
  • View the full release here: https://www.businesswire.com/news/home/20230316005608/en/
    Options today announced it has raised £25,000 for PIPS Suicide Prevention Ireland, a Northern Ireland based charity that provides counselling and support to individuals and organisations that have been affected by suicide.
  • The money will go towards supporting the vital work that PIPS does in providing immediate and ongoing support to those affected by suicide, as well as promoting suicide prevention and mental health awareness in the community.
  • "We are delighted to receive this generous donation from Options Technology," said Renée Quinn , Executive Director of PIPS.

Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing

Retrieved on: 
Tuesday, December 6, 2022
National University of Singapore, Applied science, Biocatalysis, Interdisciplinarity, Agency, Disease, Associate, Biology, SIT, Assistant, EDB, D, Robotics, National university, Partnership, Carbon, GSK, Sustainability, Learning, Ecosystem, 2025, NUS, Science and Engineering Research Council, Vaccine, Environment, Agency for Science, Technology and Research, COVID-19, Innovation, Machine learning, Shannon Applied Biotechnology Centre, Biomedicine, Enablement, NTU, Singapore Institute of Technology, Nanyang Technological University, Pandemic, Committee on the Office of the Deputy Prime Minister, PIPS, Analytics, A*STAR, Biomedical Research Council, Framework Programmes for Research and Technological Development, Pharmaceutical industry, Management, Fine chemical, Sanofi, Research, Science, Takeda

BioPIPS seeks to use research and innovation to grow Singapore's manufacturing capabilities for biologics, which include recombinant therapeutic proteins, and vaccines.

Key Points: 
  • BioPIPS seeks to use research and innovation to grow Singapore's manufacturing capabilities for biologics, which include recombinant therapeutic proteins, and vaccines.
  • Amid the COVID-19 pandemic, biologics and vaccines played a critical role globally in preventing severe disease and saving lives.
  • The consortium ultimately aims to make Singapore's biologics manufacturing capabilities best-in-class and well-positioned for the introduction of new products and novel manufacturing technologies.
  • "Riding on the success of PIPS, BioPIPS aims to enhance Singapore's innovation capabilities in biologics and vaccines manufacturing by leveraging the strengths of our leading pharmaceutical companies and institutes of higher learning.

Ibex Selected by India's Dr. Lal PathLabs to Deliver AI-powered Cancer Diagnostics

Retrieved on: 
Wednesday, November 24, 2021
Patient, NSE, Algorithm, Intelligence, Asia, Regulation of tobacco by the U.S. Food and Drug Administration, Accreditation, PIPS, CAP, Technology, Philips, CE, PHG, Time, NYSE, Google Images, Partnership, Diagnosis, News, Health, Cancer, WSI, Artificial intelligence, Breast, SE, Laboratory, Prognosis, Physician, EUR, Machine learning, ISO, Innovation, Efficiency, Jen-Ai Hospital, FDA, TEL, Oncology, NEW, National Stock Exchange, Ibex, College, Translation, National Board of Chiropractic Examiners, AEX, Marie Cassidy, Disease, List of pathologists, Pathology, Food, Deep learning, Medical device, Medical imaging

NEW DELHI, India, and TEL AVIV, Israel, Nov. 24, 2021 /PRNewswire/ -- Dr. Lal PathLabs, one of the largest chains of pathology labs in South East Asia, and Ibex Medical Analytics, the market leader in artificial intelligence (AI)-powered cancer diagnostics, today announced the first deployment in India of an AI platform that supports pathologists during routine cancer diagnosis and helps improve the quality and turnaround time of cancer tests.

Key Points: 
  • Ibex transforms cancer diagnosis by harnessing artificial intelligence and machine learning technologies at an unprecedented scale.
  • Ibex's Galen platform helps pathologists improve the quality of cancer diagnosis, implement real-time quality control1, reduce diagnosis time and boost productivity2.
  • Dr. Lal PathLabs Ltd is one the largest chain of pathology labs in SE Asia.We at Dr. Lal PathLabs have committed ourselves to a vision.
  • Dr. Lal PathLabsislisted on National Stock Exchange (NSE) India, making the organisation the first one to go public in the Indian Diagnostics Industry.

BlueSky Wealth Advisors Selects Entreda To Provide Industry-Leading Cybersecurity Compliance Platform

Retrieved on: 
Wednesday, September 15, 2021
Unify, CEO, PIPS, Blue, Insurance, Freedom, Hunger, RIAS, Industry, Solution, Compliance, Organization, Time, RIA, Awareness, Financial adviser, Risk management

BlueSky's selection of Entreda over a range of other prominent cybersecurity providers is more evidence of Entreda's position as the top cybersecurity provider to successful wealth management firms and specifically fast-growing, innovative RIA firms.

Key Points: 
  • BlueSky's selection of Entreda over a range of other prominent cybersecurity providers is more evidence of Entreda's position as the top cybersecurity provider to successful wealth management firms and specifically fast-growing, innovative RIA firms.
  • Entreda's platforms and solutions provide deep visibility on the cybersecurity posture of an organization's users, devices, networks and vendors.
  • We are thrilled to partner with a forward-thinking firm like BlueSky for their cybersecurity compliance needs.
  • BlueSky Wealth Advisors is a trailblazing financial advisory firm introducing a proprietary and innovative fee structure to the fee-only, Registered Investment Advisor (RIA) space.